Advertisement
YOU ARE HERE: LAT HomeCollections

BRIEFLY

Health Care

August 11, 1994|From Times Staff and Wire Reports

Biotech Provisions Dropped from Health Reform Bill: House Majority Leader Rep. Richard Gephardt (D-Mo.) has dropped a 15% Medicare rebate requirement for biotechnology companies from his health care reform bill, industry and congressional sources said. Gephardt has also scrapped a commission that would review drug prices to be used in the Medicare program, according to Rep. Anna Eshoo (D-Calif.). The biotech industry has strongly opposed the price commission and the rebate as price controls that would reduce capital investment in the industry and inhibit research.

Advertisement
Los Angeles Times Articles
|
|
|